REPATHA
REPATHA
Approved
DIN Number
02459779
Drug Class
Human
Market Date
Apr 4, 2017
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02459779
AIG Number0157370002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
C10AX13 EVOLOCUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification24:06.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
EVOLOCUMABActive
Strength: 120 MG / ML
Monograph: EVOLOCUMAB